AxSpA Podcast: Safety and Efficacy of Tofacitinib and Bimekizumab

from The IMID Forum · host The Immune-Mediated Inflammatory Disease Forum

Join Doctor Sofia Ramiro as she is joined by Professors Atul Deodhar and Xenofon Baraliakos to discuss the latest top clinical research in the world of axSpA. In the first paper discussed, the authors evaluated the efficacy and safety of tofacitinib in bDMARD-naïve and TNF-IR AS patients. The second paper presents the results of two parallel clinical trials that investigated the safety and efficacy of bimekizumab.

Episode metadata supplied by the publisher feed · Published Dec 4, 2023

Embed this episode

Attribution link and audio player

Ready to play

AxSpA Podcast: Safety and Efficacy of Tofacitinib and Bimekizumab

0:00 33:10

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The IMID Forum?

This episode is 33 minutes long.

When was this The IMID Forum episode published?

This episode was published on December 4, 2023.

Can I download this The IMID Forum episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!